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Peptide-based hydrogels constitute an important class of biomaterials with a wide range of applications, which 
include among others drug delivery, tissue engineering, in vivo imaging and template materials. Particularly, 
naproxen-containing peptide-derived hydrogels have been successfully synthesized and evaluated as drug 
nanocarriers [1,2].  
The incorporation of magnetic nanoparticles in these biocompatible nanosystems, forming nanomagnetogels, will 
allow their concentration in the desired area of the patient’s organs by magnetic forces, allowing the guided transport 
of biologically active substances, most of them toxic and with systemic side effects. A promising application of these 
nanomagnetogels in cancer therapy is anticipated, through magnetically-guided drug delivery and hyperthermia [3]. 
Moreover, targeted therapy is also being addressed through hydrogels with the RGD sequence (arginine-glycine-
aspartic acid; Arg-Gly-Asp), recognized by integrins, these receptors being involved in the regulation of cellular 
proliferation and apoptosis. The integrin αvβ3 is overexpressed in some tumor cells and has been implicated in the 
growth of solid tumours and in the development of metastases. 
In this work, iron oxide nanoparticles, with diameters around 12 nm (Fig. 1), were synthesized by coprecipitation 
method in aqueous solution. These nanoparticles exhibit a superparamagnetic behavior, with a coercive field of 
9.7 Oe and a blocking temperature of 118 K [4]. 
The nanoparticles were successfully incorporated in peptide-based hydrogels containing naproxen (Npx) and/or 
RGD (Fig. 2). The ability of these magnetogels to act as drug nanocarriers is being investigated, aiming at 
developing multifunctional therapeutic nanosystems. 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 1: SEM image of iron oxide 
nanoparticles. Inset: Particles size 
histogram and fitting to a Gaussian 
distribution. 
 
 
 
 
 
 
 
 
 
 
 
Fig. 2: TEM images of hydrogels. A: Npx-Phe-∆Abu-OH.  
B: Npx-Ala-∆Phe-Gly-Arg-Gly-Asp-Gly-OH.  
(Npx: Naproxen; Phe: Phenylalanine; Abu: Aminobutyric acid;  
Ala: Alanine; Gly: Glycine; Arg: Arginine; Asp: Aspartic acid). 
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